APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Anesthesia

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhalation Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025189 pages

Choose your research edition.

Industry ResearchInhalation Anesthesia Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Anesthesia Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Inhalation Anesthesia Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Anesthesia Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Anesthesia Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Inhalation Anesthesia market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhalation Anesthesia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation Anesthesia include Lunan Pharmaceutical Group Co.Ltd., Jiangsu Hengrui Medicine Co. Ltd., Fresenius Kabi Ag, Baxter, AbbVie Inc., Piramal Enterprises Limited, Hikma Pharmaceuticals PLC and Halocarbon Products Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhalation Anesthesia market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhalation Anesthesia and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhalation Anesthesia sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhalation Anesthesia market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhalation Anesthesia Segment by Company

Lunan Pharmaceutical Group Co.Ltd.

Jiangsu Hengrui Medicine Co. Ltd.

Fresenius Kabi Ag

Baxter

AbbVie Inc.

Piramal Enterprises Limited

Hikma Pharmaceuticals PLC

Halocarbon Products Corporation

Inhalation Anesthesia Segment by Type

Isoflurane

Sevoflurane

Desflurane

Inhalation Anesthesia Segment by Application

Induction

Maintenance

Inhalation Anesthesia Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Anesthesia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Anesthesia and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Anesthesia.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhalation Anesthesia market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation Anesthesia manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhalation Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhalation Anesthesia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhalation Anesthesia Industry Trends Table 2. Inhalation Anesthesia Industry Drivers Table 3. Inhalation Anesthesia Industry Opportunities and Challenges Table 4. Inhalation Anesthesia Industry Restraints Table 5. Global Inhalation Anesthesia Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhalation Anesthesia Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhalation Anesthesia Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inhalation Anesthesia Sales Market Share by Manufacturers Table 9. Global Inhalation Anesthesia Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inhalation Anesthesia Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhalation Anesthesia Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhalation Anesthesia Manufacturers, Product Type & Application Table 13. Global Inhalation Anesthesia Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhalation Anesthesia by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Isoflurane Table 17. Major Manufacturers of Sevoflurane Table 18. Major Manufacturers of Desflurane Table 19. Global Inhalation Anesthesia Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhalation Anesthesia Sales by Type (2021-2026) & (K Units) Table 21. Global Inhalation Anesthesia Sales by Type (2027-2032) & (K Units) Table 22. Global Inhalation Anesthesia Sales Market Share by Type (2021-2026) Table 23. Global Inhalation Anesthesia Sales Market Share by Type (2027-2032) Table 24. Global Inhalation Anesthesia Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Inhalation Anesthesia Revenue by Type (2021-2026) & (K Units) Table 26. Global Inhalation Anesthesia Revenue by Type (2027-2032) & (K Units) Table 27. Global Inhalation Anesthesia Revenue Market Share by Type (2021-2026) Table 28. Global Inhalation Anesthesia Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Induction Table 30. Major Manufacturers of Maintenance Table 31. Global Inhalation Anesthesia Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Inhalation Anesthesia Sales by Application (2021-2026) & (K Units) Table 33. Global Inhalation Anesthesia Sales by Application (2027-2032) & (K Units) Table 34. Global Inhalation Anesthesia Sales Market Share by Application (2021-2026) Table 35. Global Inhalation Anesthesia Sales Market Share by Application (2027-2032) Table 36. Global Inhalation Anesthesia Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Inhalation Anesthesia Revenue by Application (2021-2026) & (K Units) Table 38. Global Inhalation Anesthesia Revenue by Application (2027-2032) & (K Units) Table 39. Global Inhalation Anesthesia Revenue Market Share by Application (2021-2026) Table 40. Global Inhalation Anesthesia Revenue Market Share by Application (2027-2032) Table 41. Global Inhalation Anesthesia Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Inhalation Anesthesia Sales by Region (2021-2026) & (K Units) Table 43. Global Inhalation Anesthesia Sales Market Share by Region (2021-2026) Table 44. Global Inhalation Anesthesia Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Inhalation Anesthesia Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Inhalation Anesthesia Sales by Country (2021-2026) & (K Units) Table 48. North America Inhalation Anesthesia Sales by Country (2027-2032) & (K Units) Table 49. Europe Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Inhalation Anesthesia Sales by Country (2021-2026) & (K Units) Table 51. Europe Inhalation Anesthesia Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Inhalation Anesthesia Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Inhalation Anesthesia Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Inhalation Anesthesia Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Inhalation Anesthesia Sales by Country (2027-2032) & (K Units) Table 58. Global Inhalation Anesthesia Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Inhalation Anesthesia Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Inhalation Anesthesia Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Inhalation Anesthesia Revenue Market Share by Region (2021-2026) Table 62. Global Inhalation Anesthesia Revenue Market Share by Region (2027-2032) Table 63. Lunan Pharmaceutical Group Co.Ltd. Company Information Table 64. Lunan Pharmaceutical Group Co.Ltd. Business Overview Table 65. Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Product Portfolio Table 67. Lunan Pharmaceutical Group Co.Ltd. Recent Development Table 68. Jiangsu Hengrui Medicine Co. Ltd. Company Information Table 69. Jiangsu Hengrui Medicine Co. Ltd. Business Overview Table 70. Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Product Portfolio Table 72. Jiangsu Hengrui Medicine Co. Ltd. Recent Development Table 73. Fresenius Kabi Ag Company Information Table 74. Fresenius Kabi Ag Business Overview Table 75. Fresenius Kabi Ag Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Fresenius Kabi Ag Inhalation Anesthesia Product Portfolio Table 77. Fresenius Kabi Ag Recent Development Table 78. Baxter Company Information Table 79. Baxter Business Overview Table 80. Baxter Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Baxter Inhalation Anesthesia Product Portfolio Table 82. Baxter Recent Development Table 83. AbbVie Inc. Company Information Table 84. AbbVie Inc. Business Overview Table 85. AbbVie Inc. Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. AbbVie Inc. Inhalation Anesthesia Product Portfolio Table 87. AbbVie Inc. Recent Development Table 88. Piramal Enterprises Limited Company Information Table 89. Piramal Enterprises Limited Business Overview Table 90. Piramal Enterprises Limited Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Piramal Enterprises Limited Inhalation Anesthesia Product Portfolio Table 92. Piramal Enterprises Limited Recent Development Table 93. Hikma Pharmaceuticals PLC Company Information Table 94. Hikma Pharmaceuticals PLC Business Overview Table 95. Hikma Pharmaceuticals PLC Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Hikma Pharmaceuticals PLC Inhalation Anesthesia Product Portfolio Table 97. Hikma Pharmaceuticals PLC Recent Development Table 98. Halocarbon Products Corporation Company Information Table 99. Halocarbon Products Corporation Business Overview Table 100. Halocarbon Products Corporation Inhalation Anesthesia Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Halocarbon Products Corporation Inhalation Anesthesia Product Portfolio Table 102. Halocarbon Products Corporation Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Inhalation Anesthesia Distributors List Table 106. Inhalation Anesthesia Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Inhalation Anesthesia Product Image Figure 2. Global Inhalation Anesthesia Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Anesthesia Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation Anesthesia Sales (2021-2032) & (K Units) Figure 5. Global Inhalation Anesthesia Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhalation Anesthesia Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Isoflurane Image Figure 9. Sevoflurane Image Figure 10. Desflurane Image Figure 11. Global Inhalation Anesthesia Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhalation Anesthesia Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Inhalation Anesthesia Sales Market Share by Type (2021-2032) Figure 14. Global Inhalation Anesthesia Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Inhalation Anesthesia Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Inhalation Anesthesia Revenue Market Share by Type (2021-2032) Figure 17. Induction Image Figure 18. Maintenance Image Figure 19. Global Inhalation Anesthesia Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Inhalation Anesthesia Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Inhalation Anesthesia Sales Market Share by Application (2021-2032) Figure 22. Global Inhalation Anesthesia Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Inhalation Anesthesia Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Inhalation Anesthesia Revenue Market Share by Application (2021-2032) Figure 25. North America Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Inhalation Anesthesia Sales Market Share by Country (2021-2032) Figure 27. U.S. Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Inhalation Anesthesia Sales Market Share by Country (2021-2032) Figure 32. Germany Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Inhalation Anesthesia Sales Market Share by Country (2021-2032) Figure 39. China Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Inhalation Anesthesia Sales Market Share by Country (2021-2032) Figure 47. Brazil Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Inhalation Anesthesia Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Inhalation Anesthesia Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Inhalation Anesthesia Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Inhalation Anesthesia Revenue (2021-2032) & (US$ Million) Figure 58. North America Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Inhalation Anesthesia Revenue (2021-2032) & (US$ Million) Figure 60. Europe Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Inhalation Anesthesia Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Inhalation Anesthesia Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Inhalation Anesthesia Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Inhalation Anesthesia Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Isoflurane
  • Sevoflurane
  • Desflurane
Applications
  • Induction
  • Maintenance
Companies covered
  • Lunan Pharmaceutical Group Co.Ltd.
  • Jiangsu Hengrui Medicine Co. Ltd.
  • Fresenius Kabi Ag
  • Baxter
  • AbbVie Inc.
  • Piramal Enterprises Limited
  • Hikma Pharmaceuticals PLC
  • Halocarbon Products Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhalation Anesthesia Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhalation Anesthesia Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhalation Anesthesia Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhalation Anesthesia Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhalation Anesthesia Market Dynamics
  1. 2.1 Inhalation Anesthesia Industry Trends
  2. 2.2 Inhalation Anesthesia Industry Drivers
  3. 2.3 Inhalation Anesthesia Industry Opportunities and Challenges
  4. 2.4 Inhalation Anesthesia Industry Restraints
3 Inhalation Anesthesia Market by Manufacturers
  1. 3.1 Global Inhalation Anesthesia Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhalation Anesthesia Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhalation Anesthesia Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhalation Anesthesia Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation Anesthesia Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhalation Anesthesia Manufacturers, Product Type & Application
  7. 3.7 Global Inhalation Anesthesia Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation Anesthesia Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation Anesthesia Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation Anesthesia Tier 1, Tier 2, and Tier 3
4 Inhalation Anesthesia Market by Type
  1. 4.1 Inhalation Anesthesia Type Introduction
  2. 4.1.1 Isoflurane
  3. 4.1.2 Sevoflurane
  4. 4.1.3 Desflurane
  5. 4.2 Global Inhalation Anesthesia Sales by Type
  6. 4.2.1 Global Inhalation Anesthesia Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhalation Anesthesia Sales by Type (2021-2032)
  8. 4.2.3 Global Inhalation Anesthesia Sales Market Share by Type (2021-2032)
  9. 4.3 Global Inhalation Anesthesia Revenue by Type
  10. 4.3.1 Global Inhalation Anesthesia Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhalation Anesthesia Revenue by Type (2021-2032)
  12. 4.3.3 Global Inhalation Anesthesia Revenue Market Share by Type (2021-2032)
5 Inhalation Anesthesia Market by Application
  1. 5.1 Inhalation Anesthesia Application Introduction
  2. 5.1.1 Induction
  3. 5.1.2 Maintenance
  4. 5.2 Global Inhalation Anesthesia Sales by Application
  5. 5.2.1 Global Inhalation Anesthesia Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Inhalation Anesthesia Sales by Application (2021-2032)
  7. 5.2.3 Global Inhalation Anesthesia Sales Market Share by Application (2021-2032)
  8. 5.3 Global Inhalation Anesthesia Revenue by Application
  9. 5.3.1 Global Inhalation Anesthesia Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Inhalation Anesthesia Revenue by Application (2021-2032)
  11. 5.3.3 Global Inhalation Anesthesia Revenue Market Share by Application (2021-2032)
6 Global Inhalation Anesthesia Sales by Region
  1. 6.1 Global Inhalation Anesthesia Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhalation Anesthesia Sales by Region (2021-2032)
  3. 6.2.1 Global Inhalation Anesthesia Sales by Region (2021-2026)
  4. 6.2.2 Global Inhalation Anesthesia Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhalation Anesthesia Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhalation Anesthesia Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhalation Anesthesia Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhalation Anesthesia Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhalation Anesthesia Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhalation Anesthesia Revenue by Region
  1. 7.1 Global Inhalation Anesthesia Revenue by Region
  2. 7.1.1 Global Inhalation Anesthesia Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhalation Anesthesia Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhalation Anesthesia Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhalation Anesthesia Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhalation Anesthesia Revenue (2021-2032)
  8. 7.2.2 North America Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhalation Anesthesia Revenue (2021-2032)
  11. 7.3.2 Europe Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhalation Anesthesia Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhalation Anesthesia Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhalation Anesthesia Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lunan Pharmaceutical Group Co.Ltd.
  2. 8.1.1 Lunan Pharmaceutical Group Co.Ltd. Company Information
  3. 8.1.2 Lunan Pharmaceutical Group Co.Ltd. Business Overview
  4. 8.1.3 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lunan Pharmaceutical Group Co.Ltd. Inhalation Anesthesia Product Portfolio
  6. 8.1.5 Lunan Pharmaceutical Group Co.Ltd. Recent Developments
  7. 8.2 Jiangsu Hengrui Medicine Co. Ltd.
  8. 8.2.1 Jiangsu Hengrui Medicine Co. Ltd. Company Information
  9. 8.2.2 Jiangsu Hengrui Medicine Co. Ltd. Business Overview
  10. 8.2.3 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hengrui Medicine Co. Ltd. Inhalation Anesthesia Product Portfolio
  12. 8.2.5 Jiangsu Hengrui Medicine Co. Ltd. Recent Developments
  13. 8.3 Fresenius Kabi Ag
  14. 8.3.1 Fresenius Kabi Ag Company Information
  15. 8.3.2 Fresenius Kabi Ag Business Overview
  16. 8.3.3 Fresenius Kabi Ag Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Ag Inhalation Anesthesia Product Portfolio
  18. 8.3.5 Fresenius Kabi Ag Recent Developments
  19. 8.4 Baxter
  20. 8.4.1 Baxter Company Information
  21. 8.4.2 Baxter Business Overview
  22. 8.4.3 Baxter Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Baxter Inhalation Anesthesia Product Portfolio
  24. 8.4.5 Baxter Recent Developments
  25. 8.5 AbbVie Inc.
  26. 8.5.1 AbbVie Inc. Company Information
  27. 8.5.2 AbbVie Inc. Business Overview
  28. 8.5.3 AbbVie Inc. Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AbbVie Inc. Inhalation Anesthesia Product Portfolio
  30. 8.5.5 AbbVie Inc. Recent Developments
  31. 8.6 Piramal Enterprises Limited
  32. 8.6.1 Piramal Enterprises Limited Company Information
  33. 8.6.2 Piramal Enterprises Limited Business Overview
  34. 8.6.3 Piramal Enterprises Limited Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Piramal Enterprises Limited Inhalation Anesthesia Product Portfolio
  36. 8.6.5 Piramal Enterprises Limited Recent Developments
  37. 8.7 Hikma Pharmaceuticals PLC
  38. 8.7.1 Hikma Pharmaceuticals PLC Company Information
  39. 8.7.2 Hikma Pharmaceuticals PLC Business Overview
  40. 8.7.3 Hikma Pharmaceuticals PLC Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Pharmaceuticals PLC Inhalation Anesthesia Product Portfolio
  42. 8.7.5 Hikma Pharmaceuticals PLC Recent Developments
  43. 8.8 Halocarbon Products Corporation
  44. 8.8.1 Halocarbon Products Corporation Company Information
  45. 8.8.2 Halocarbon Products Corporation Business Overview
  46. 8.8.3 Halocarbon Products Corporation Inhalation Anesthesia Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Halocarbon Products Corporation Inhalation Anesthesia Product Portfolio
  48. 8.8.5 Halocarbon Products Corporation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhalation Anesthesia Value Chain Analysis
  2. 9.1.1 Inhalation Anesthesia Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhalation Anesthesia Production Mode & Process
  6. 9.2 Inhalation Anesthesia Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhalation Anesthesia Distributors
  9. 9.2.3 Inhalation Anesthesia Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst